1VMP
STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
Summary for 1VMP
Entry DOI | 10.2210/pdb1vmp/pdb |
Descriptor | PROTEIN (ANTI-HIV CHEMOKINE MIP VII) (1 entity in total) |
Functional Keywords | vmip-ii, chemokine, monomer, sarcoma, herpesvirus, hhv-8, kaposi's, antiviral protein |
Biological source | Human herpesvirus 8 |
Cellular location | Secreted: Q98157 |
Total number of polymer chains | 1 |
Total formula weight | 8142.66 |
Authors | Liwang, A.C.,Wang, Z.-X.,Sun, Y.,Peiper, S.C.,Liwang, P.J. (deposition date: 1999-03-25, release date: 1999-11-24, Last modification date: 2024-11-20) |
Primary citation | Liwang, A.C.,Wang, Z.X.,Sun, Y.,Peiper, S.C.,Liwang, P.J. The solution structure of the anti-HIV chemokine vMIP-II. Protein Sci., 8:2270-2280, 1999 Cited by PubMed Abstract: We report the solution structure of the chemotactic cytokine (chemokine) vMIP-II. This protein has unique biological activities in that it blocks infection by several different human immunodeficiency virus type 1 (HIV-1) strains. This occurs because vMIP-II binds to a wide range of chemokine receptors, some of which are used by HJV to gain cell entry. vMIP-II is a monomeric protein, unlike most members of the chemokine family, and its structure consists of a disordered N-terminus, followed by a helical turn (Gln25-Leu27), which leads into the first strand of a three-stranded antiparallel beta-sheet (Ser29-Thr34; Gly42-Thr47; Gln52-Asp56). Following the sheet is a C-terminal alpha-helix, which extends from residue Asp60 until Gln68. The final five residues beyond the C-terminal helix (Pro70-Arg74) are in an extended conformation, but several of these C-terminal residues contact the first beta-strand. The structure of vMIP-II is compared to other chemokines that also block infection by HIV-1, and the structural basis of its lack of ability to form a dimer is discussed. PubMed: 10595530PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
